Evidence map›Paper›PMID 41429668›Full record

ArticleThe Journal of international medical research2025

Successful dual therapy of aztreonam and ceftazidime-avibactam for multidrug-resistant

Abdulrahman O Alghamdi, Abdulelah S Algethami, Majed S Aljuaeed, Faisal M Alkhammash, Faisal M Almalki, Sultan A Alharthi, Nejood M Aljaed, Salma As Abosabie, Sara A Abosabie, Naglaa M Kamal

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of international medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Abdulrahman O AlghamdiPediatric Department, Infectious Disease Division, Alhada Armed Forces Hospital, Saudi Arabia.
Abdulelah S AlgethamiPediatric Department, King Salman Specialized, National Guard Hospital, Saudi Arabia.
Majed S AljuaeedPediatric Department, King Salman Specialized, National Guard Hospital, Saudi Arabia.
Faisal M AlkhammashPediatric Department, Alhada Armed Forces Hospital, Saudi Arabia.
Faisal M AlmalkiCollege of Pharmacy, Taif University, Saudi Arabia.
Sultan A AlharthiPediatric Department, Alhada Armed Forces Hospital, Saudi Arabia.
Nejood M AljaedPediatric Department, Alhada Armed Forces Hospital, Saudi Arabia.
Salma As AbosabieFaculty of Medicine, Julius-Maximilians-Universität Würzburg, Germany.
Sara A AbosabieFaculty of Medicine, Charité-Universitätsmedizin Berlin, Germany.
Naglaa M KamalPediatric Department, Kasralainy Faculty of Medicine, Cairo University, Egypt.ORCID 0000-0002-8535-3838

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsAzabicyclo CompoundsAztreonamCeftazidimeDrug Resistance, Multiple, BacterialGram-Negative Bacterial InfectionsStenotrophomonas maltophiliaDrug CombinationsDrug Therapy, CombinationHumansInfant, NewbornInfant, PrematureMaleAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsAztreonamCeftazidimeDrug Combinationsaztreonam and ceftazidime–avibactamDual therapymultidrug-resistantneonatepretermStenotrophomonas maltophilia

Identifiers

PMID41429668
PMCPMC12743881

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.